Radiation Exposure News and Research

RSS

Researchers say breast cancer screening requires a personalized approach

Researchers at Moffitt Cancer Center predict that advancements in breast cancer screening will need a personalized touch because mammography is not a "one strategy fits all" technology.

5 Apr 2013

Integrated advanced cardiovascular imaging modalities can change cardiac care

Focusing on problem solving clinical approach, places the emphasis firmly on identifying the best test to answer each specific question in the most efficient way.

4 Apr 2013

Research shows THz pulses destroy skin tissue and increase tumor-suppressing proteins

Terahertz (THz) radiation, a slice of the electromagnetic spectrum that occupies the middle ground between microwaves and infrared light, is rapidly finding important uses in medical diagnostics, security, and scientific research. As scientists and engineers find evermore practical uses for this form of radiation, questions persist about its potential human health risks.

15 Mar 2013

Maintaining high-quality CT colonography while reducing radiation dose is possible, finds study

A new study by a Rhode Island Hospital researcher has found it's possible to maintain high-quality CT colonography diagnostic images while reducing the radiation dose.

13 Mar 2013

Research roundup: Insurance coverage and access to care in Massachusetts

With increasing interest in public health problems such as obesity and alcohol and tobacco use, lawmakers are increasingly considering using policy to modify behavior. According to the authors, little is currently known about the public's willingness to accept such policies.

11 Mar 2013

Lower back pain and spinal cancer: an interview with Dr Nicholas Henschke, University of Heidelberg

While lower back pain is a common condition around the world, in only a very small proportion of people – less than 5% - will this be caused by a serious problem such as fracture, infection, or tumour.

7 Mar 2013

Fukushima report sheds light on future health risks

A detailed report carried out by the World Health Organization estimates that the risk to the general public inside and outside Japan from the Fukushima nuclear accident is minimal with no anticipated increases in cancer rates.

6 Mar 2013

Breast cancer tests: an interview with Dr Steven Quay, CEO of Atossa Genetics

Breast cancer is a major concern throughout the world. It is the number 1 cancer among women and in the Western world it generates approximately one new case per minute: 24 hours a day 7 days a week.

22 Feb 2013

Landauer reports revenue of $36.7 million for first quarter 2013

Landauer, Inc., a recognized leader in personal and environmental radiation measurement and monitoring, outsourced medical physics services and high quality medical consumable accessories, today reported financial results for its fiscal 2013 first quarter ended December 31, 2012.

11 Feb 2013

Seven factors rule out CT for children with abdominal injury

Research shows that children presenting with abdominal injury at an emergency department who lack seven key factors are extremely unlikely to have an injury requiring acute intervention and therefore do not require computed tomography scanning.

5 Feb 2013

Epidermal growth factor speeds recovery of blood-making stem cells after radiation exposure

Epidermal growth factor has been found to speed the recovery of blood-making stem cells after exposure to radiation, according to Duke Medicine researchers. The finding could open new options for treating cancer patients and victims of dirty bombs or nuclear disasters.

3 Feb 2013

Researchers identify 7 factors to lessen radiation exposure in young, traumatic injury victims

A study of more than 12,000 children from emergency departments throughout the country in the Pediatric Emergency Care Applied Research Network (PECARN) has identified seven factors that can help physicians determine the need for a computed tomography (CT) scan following blunt trauma to the abdomen.

2 Feb 2013

New CT system reduces radiation exposure in patients undergoing CCTA

Researchers using a newly approved advanced computed tomography (CT) system were able to significantly reduce radiation exposure in patients undergoing coronary CT angiography (CCTA), according to a new study published online in the journal Radiology.

1 Feb 2013

Microscopic hematuria poor indicator for renal, bladder malignancy

The presence of microscopic levels of blood in the urine is unreliable as an indicator for renal or bladder cancer, report researchers.

30 Jan 2013

Radial approach for PCI leads to less bleeding and improved survival in STEMI patients

The radial approach for percutaneous coronary interventions (PCI) was developed 20 years ago and is used for more than 50% of procedures in France, Scandinavian countries, the UK, Spain and Italy. Despite the advantages of radial access some countries in Europe such as Germany use radial access for fewer than 10% of PCI.

29 Jan 2013

Life Technologies, ASU partner on new project to quickly measure radiation exposure

Arizona State University's Biodesign Institute- has announced a partnership with Life Technologies Corporation as it enters the next phase of a multi-million-dollar, multi-institutional research project to develop a medical device to rapidly assess an individual's exposure to radiation in the event of a nuclear incident.

18 Jan 2013

Study reports on development and testing of Hematuria Risk Index to predict cancer risk

Microscopic amounts of blood in urine have been considered a risk factor for urinary tract malignant tumors. However, only a small proportion of patients referred for investigation are subsequently found to have cancer. A new Kaiser Permanente Southern California study published in the February Mayo Clinic Proceedings reports on the development and testing of a Hematuria Risk Index to predict cancer risk.

10 Jan 2013

Soligenix's OrbeShield granted FDA oral BDP orphan drug designation

Soligenix, Inc., a development stage biopharmaceutical company, announced today that the Office of Orphan Products Development of the US Food and Drug Administration (FDA) has granted orphan drug designation to OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP) for the prevention of death following a potentially lethal dose of total body irradiation during or after a radiation disaster.

2 Jan 2013

CAC test can identify diabetes patients at high risk of fatal cardiovascular disease

People with Type 2 diabetes have two to four times the risk of cardiovascular disease compared to people without the disease. The best way for doctors to predict which diabetes patients are at the greatest risk for heart disease is to use a coronary artery calcium (CAC) test in addition to the most commonly used assessment tool, according to researchers at Wake Forest Baptist Medical Center.

21 Dec 2012

Elekta receives clearance for Clarity 4D Monitoring software

Elekta has received 510(k) clearance for its Clarity 4D Monitoring software, enabling U.S. medical centers to implement this new way of reducing the uncertainty caused by prostate motion during radiation treatment.

From Elekta 17 Dec 2012